Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cabenuva
Pharma
ViiV girds data package for Cabenuva in competitive HIV market
Cabenuva hit superior viral suppression versus oral antiretrovirals in adults and adolescents with HIV-1 with viremia in the phase 3b Crown study.
Fraiser Kansteiner
Oct 6, 2026 10:59am
ViiV targets ‘future you’ in long-acting HIV campaign
Aug 6, 2026 8:46am
GSK props up its Cabenuva in adolescents with long-term data
Feb 26, 2026 1:00pm
Pfizer unleashes its stake in GSK's ViiV Healthcare for $1.9B
Jan 20, 2026 10:15am
GSK allows generic versions of cabotegravir for HIV treatment
Jul 15, 2025 2:16pm
Vyvgart, Cabenuva, Lumakras top Trinity launch success analysis
Mar 12, 2025 2:13pm
